The orthopedic biomaterials market is expected to witness a value-based growth rate of 8.70% from 2020, reaching a market size of USD 28.38 Billion by 2028. The market growth can be attributed to the increasing prevalence of target conditions.
The rise in chronic skeletal conditions is a key driver for market growth during the forecast period. Childhood chronic diseases often lead to skeletal fragility, characterized by poor bone growth, reduced bone turnover, and abnormalities in bone geometry, mass, and microarchitecture.
https://www.reportsanddata.com..../report-detail/ortho